Cidofovir: progress in the treatment of progressive multifocal encephalopathy (PML)?
Wilcox
Ronald D
RD
Section of Infectious Disease, LSU Health Sciences Center, Medical Center of Louisiana, New Orleans, USA.
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D019562:Viral Load
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir